<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="65285">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01696838</url>
  </required_header>
  <id_info>
    <org_study_id>SHACU-201201</org_study_id>
    <nct_id>NCT01696838</nct_id>
  </id_info>
  <brief_title>Efficacy of Acupuncture and Moxibustion Treatment in Patients With Quiescent Crohn's Disease:Evaluation With fMRI</brief_title>
  <official_title>Efficacy of Acupuncture and Moxibustion Treatment in Patients With Quiescent Crohn's Disease:Evaluation With Functional Magnetic Resonance Imaging(fMRI)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shanghai Institute of Acupuncture, Moxibustion and Meridian</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shanghai Institute of Acupuncture, Moxibustion and Meridian</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
    <authority>China: Ethics Committee</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether acupuncture or moxibustion therapies are
      effective in the treatment of Crohn's disease. Meanwhile, the investigators aim to evaluate
      the efficacy by functional magnetic resonance imaging.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is to determine whether acupuncture or moxibustion therapies are
      effective in the treatment of Crohn's disease. meanwhile, the investigators aim to evaluate
      the efficacy by functional magnetic resonance imaging.

      Through treating quiescent Crohn's disease by electroacupuncture or moxibustion therapies
      for 12 weeks, Compare the different brain activation by the different therapies and observe
      the correlation between brain activation and efficacy.
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date>September 2012</start_date>
  <completion_date type="Anticipated">April 2014</completion_date>
  <primary_completion_date type="Anticipated">March 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Investigator, Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>CDAI</measure>
    <time_frame>1 year</time_frame>
    <safety_issue>No</safety_issue>
    <description>Crohn's Disease Activity Index</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>fMRI</measure>
    <time_frame>1 year</time_frame>
    <safety_issue>No</safety_issue>
    <description>Brain activiation tested by BOLD fMRI</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>IBDQ</measure>
    <time_frame>1 year</time_frame>
    <safety_issue>No</safety_issue>
    <description>Inflammatory Bowel Disease Questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inflammatory factors</measure>
    <time_frame>1 and a half years</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Intestinal mucosa of IL-6,IL-17,IL-23,etc</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neurotransmitter</measure>
    <time_frame>1 and a half years</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>5-HT,DA,etc</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">72</enrollment>
  <condition>Crohn's Disease</condition>
  <condition>CAM</condition>
  <arm_group>
    <arm_group_label>EA group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Electroacupuncture group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MOX group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Herbs-partitioned moxibustion group</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>electroacupuncture</intervention_name>
    <description>Patients receive electroacupuncture for 30 minutes with a stimulation frequency of 2 /100 Hz and a stimulation intensity varying from 0.1 to 1.0 mA.3 times per week,the duration is 12 weeks.</description>
    <arm_group_label>EA group</arm_group_label>
    <arm_group_label>MOX group</arm_group_label>
    <other_name>acupuncture</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>moxibustion</intervention_name>
    <description>patients receive herbs-partitioned moxibustion for 2 cones，3 times a week for 12 weeks.</description>
    <arm_group_label>EA group</arm_group_label>
    <arm_group_label>MOX group</arm_group_label>
    <other_name>herbs-partitioned moxibustion</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age 18-50 years;

          -  right-handed;

          -  clinical remission (Crohn's Disease Activity Index [CDAI]≤150) for at least 6 months
             prior to the study;

          -  C-reactive protein(CRP)&lt;10 mg/l;

          -  erythrocyte sedimentation rate (ESR) &lt;20 mm/h

          -  signing awritten informed consent form.

        Exclusion Criteria:

          -  use of corticosteroids and psychotropic medications in the previous 30 days;

          -  current or prior history of neurological or psychiatric disease based

          -  on physicians' examination and questionnaires;

          -  current or prior history of neurosurgery, head injury, cerebrovascular

          -  insult, or brain trauma involving loss of consciousness;

          -  learning disability;

          -  claustrophobia;

          -  presence of metallic implants in the body;

          -  being pregnant or during lactation.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wu Huangan, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Shanghai Institute of Acupuncture, Moxibustion and Meridian</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Shanghai Institute of Acupuncture-Moxibustion and Merdian</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200030</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>September 2012</verification_date>
  <lastchanged_date>October 28, 2013</lastchanged_date>
  <firstreceived_date>September 25, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Crohn's disease</keyword>
  <keyword>acupuncture</keyword>
  <keyword>moxibustion</keyword>
  <keyword>fMRI</keyword>
  <keyword>Gut</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Crohn Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
